Frovatriptan succinate hydrate
- Level
- Commodity
- Parent
- 51142400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142430This classification denotes a serotonin agonist with the molecular formula C14H17N3O.C4H6O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D28J6W18HY, chemically known as butanedioic acid, compd. with (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide (1:1), monohydrate, but more generally known as frovatriptan succinate hydrate, which bears US NIH Compound Identifier 152943. European Medicines Agency schedules frovatriptan succinate hydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07817MIG. Most nations, for tariff purposes, schedule frovatriptan succinate hydrate under HS 29339990. SMILES: CN[C@@H]1CCC2C(C3CC(CCC3[NH]2)C(=O)N)C1.C(CC(=O)O)C(=O)O.O.
Same parent
Under 51142400 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.